4.7 Article Proceedings Paper

Host-Pathogen Interactions Mediating Pain of Urinary Tract Infection

期刊

JOURNAL OF INFECTIOUS DISEASES
卷 201, 期 8, 页码 1240-1249

出版社

OXFORD UNIV PRESS INC
DOI: 10.1086/651275

关键词

-

资金

  1. NIDDK NIH HHS [R01 DK066112, R01DK066112, T32DK062716-05, T32 DK062716, U01 DK082342, U01 DK082342-020003, R01 DK066112-06, U01 DK082342-02] Funding Source: Medline
  2. PHS HHS [U09DKO8234] Funding Source: Medline

向作者/读者索取更多资源

Background. Pelvic pain is a major component of the morbidity associated with urinary tract infection ( UTI), yet the molecular mechanisms underlying UTI-induced pain remain unknown. UTI pain mechanisms probably contrast with the clinical condition of asymptomatic bacteriuria (ASB), characterized by significant bacterial loads without lack symptoms. Methods. A murine UTI model was used to compare pelvic pain behavior elicited by infection with uropathogenic Escherichia coli strain NU14 and ASB strain 83972. Results. NU14-infected mice exhibited pelvic pain, whereas mice infected with 83972 did not exhibit pain, similar to patients infected with 83972. NU14-induced pain was not dependent on mast cells, not correlated with bacterial colonization or urinary neutrophils. UTI pain was not influenced by expression of type 1 pili, the bacterial adhesive appendages that induce urothelial apoptosis. However, purified NU14 lipopolysaccharide (LPS) induced Toll-like receptor 4 (TLR4)-dependent pain, whereas 83972 LPS induced no pain. Indeed, 83972 LPS attenuated the pain of NU14 infection, suggesting therapeutic potential. Conclusions. These data suggest a novel mechanism of infection-associated pain that is dependent on TLR4 yet independent of inflammation. Clinically, these findings also provide the rational for probiotic therapies that would minimize the symptoms of infection without reliance on empirical therapies that contribute to antimicrobial resistance.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据